Evidence map›Paper›PMID 40951584›Full record

ArticleFood science & nutrition2025

Therapeutic Potential of

Bassam S M Al Kazman, Sadia Rana, Faiza Naseer, Taha Muhammad, Ethar Abdullah Mudhish, Mohammed A Alshamrani, Omaish S Alqahtani, Mater H Mahnashi, Mohammad Saleem

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Therapeutic Potential ofFood science & nutrition · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bassam S M Al KazmanDepartment of Pharmacognosy College of Pharmacy, Najran University Najran Saudi Arabia.
Sadia RanaUniversity College of Pharmacy University of the Punjab Lahore Pakistan.
Faiza NaseerDepartment of Biosciences Shifa Tameer e Millat University Islamabad Pakistan.ORCID https://orcid.org/0000-0002-4146-3146
Taha MuhammadShalamar Medical and Dental College Lahore Pakistan.
Ethar Abdullah MudhishDepartment of Pharmacognosy College of Pharmacy, King Khalid University Abha Kingdom of Saudi Arabia.
Mohammed A AlshamraniDepartment of Pharmaceutical Sciences, Pharmacy College Umm Al-Qura University Makkah Saudi Arabia.
Omaish S AlqahtaniDepartment of Pharmacognosy College of Pharmacy, Najran University Najran Saudi Arabia.
Mater H MahnashiDepartment of Pharmaceutical Chemistry, College of Pharmacy King Khalid University Abha Saudi Arabia.
Mohammad SaleemUniversity College of Pharmacy University of the Punjab Lahore Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a rising global health concern closely linked with obesity, insulin resistance, and metabolic syndrome. Despite its prevalence, there are currently no approved pharmacological treatments.

Indexed as

Conyza bonariensishepatoprotective activityhigh‐fat dietnon‐alcoholic fatty liver disease

Identifiers

PMID40951584
PMCPMC12426905

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.